سعر اورفينادرين بلس 50/450مجم 20 قرص 2022

• Mainly anticholinergic effects of orphenadrine: dry mouth, tachycardia, palpitations, urinary hesitancy or retention, blurred vision, pupil dilation, raised ocular pressure, weakness, nausea, headache, dizziness, constipation and drowsiness.General active-ingredient information · iNova Pharmaceuticals / medsinfo (TGA-approved PI)
• Paracetamol: rare hypersensitivity reactions, blood dyscrasias (thrombocytopenia, neutropenia, agranulocytosis) and hepatitis.General active-ingredient information · iNova Pharmaceuticals / medsinfo (TGA-approved PI)

• Glaucoma; prostatic hypertrophy or bladder-neck obstruction; myasthenia gravis; oesophageal spasm and pyloric or duodenal obstruction; hypersensitivity to paracetamol, orphenadrine citrate or any excipient.General active-ingredient information · iNova Pharmaceuticals / medsinfo (TGA-approved PI)

• Use orphenadrine with caution in tachycardia, cardiac decompensation, coronary insufficiency, arrhythmias, Gilbert syndrome and G6PD deficiency.General active-ingredient information · iNova Pharmaceuticals / medsinfo (TGA-approved PI)
• Paracetamol may cause hepatotoxicity even at therapeutic doses; avoid other paracetamol- or orphenadrine-containing medicines.General active-ingredient information · iNova Pharmaceuticals / medsinfo (TGA-approved PI)
• Serious skin reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis) have been reported with paracetamol; stop treatment if they occur.General active-ingredient information · iNova Pharmaceuticals / medsinfo (TGA-approved PI)
• Orphenadrine may impair the ability to drive or operate machinery.General active-ingredient information · iNova Pharmaceuticals / medsinfo (TGA-approved PI)

• Phenothiazines and other antimuscarinic drugsInteractions reported with orphenadrine.iNova Pharmaceuticals / medsinfo (TGA-approved PI)
• Alcohol and other CNS depressantsConcomitant use should be avoided.iNova Pharmaceuticals / medsinfo (TGA-approved PI)
• Warfarin and other vitamin K antagonistsParacetamol may increase bleeding risk; monitor coagulation.iNova Pharmaceuticals / medsinfo (TGA-approved PI)
• FlucloxacillinRisk of high anion gap metabolic acidosis due to pyroglutamic acidosis.iNova Pharmaceuticals / medsinfo (TGA-approved PI)
• Enzyme inducers (phenobarbital, phenytoin, carbamazepine, rifampicin) and alcoholIncreased risk of paracetamol hepatotoxicity.iNova Pharmaceuticals / medsinfo (TGA-approved PI)

• Australian pregnancy category B2; the product is not recommended during pregnancy.General active-ingredient information · iNova Pharmaceuticals / medsinfo (TGA-approved PI)
• Should not be taken during lactation because orphenadrine and paracetamol are excreted into breast milk.General active-ingredient information · iNova Pharmaceuticals / medsinfo (TGA-approved PI)

• If orphenadrine is used long term, periodic monitoring of blood, urine and liver function is recommended.General active-ingredient information · iNova Pharmaceuticals / medsinfo (TGA-approved PI)

English text not available for this section.